Your browser doesn't support javascript.
loading
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
Gilbert, Mark R; Gonzalez, Javier; Hunter, Kathy; Hess, Kenneth; Giglio, Pierre; Chang, Eric; Puduvalli, Vinay; Groves, Morris D; Colman, Howard; Conrad, Charles; Levin, Victor; Woo, Shaio; Mahajan, Anita; de Groot, John; Yung, W K Alfred.
Afiliação
  • Gilbert MR; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Unit 431, 1515 Holcombe Blvd., Houston, TX 77030, USA. mrgilbert@mdanderson.org
Neuro Oncol ; 12(11): 1167-72, 2010 Nov.
Article em En | MEDLINE | ID: mdl-20729242
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Supratentoriais / Glioblastoma / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2010 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Supratentoriais / Glioblastoma / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2010 Tipo de documento: Article